Xu W, Li Z, Wang C, Chen J, Wu Y, Hu R
Sci Rep. 2025; 15(1):5632.
PMID: 39955342
PMC: 11830001.
DOI: 10.1038/s41598-025-89703-9.
Coutinho D, Freitas T, Silva Batista A, Quezado de Magalhaes M, Sabino A
J Proteome Res. 2024; 23(12):5263-5273.
PMID: 39556650
PMC: 11629390.
DOI: 10.1021/acs.jproteome.4c00807.
Li D, Li J, He X, Zhang M
Cancer Med. 2024; 13(20):e70343.
PMID: 39451146
PMC: 11504202.
DOI: 10.1002/cam4.70343.
Dos Santos C, Baldivia D, de Castro D, Carvalho J, Oliveira A, Rocha P
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204079
PMC: 11357643.
DOI: 10.3390/ph17080974.
Jalal R, Shahrzad G, Roya A, Masoumeh Z
Hematol Transfus Cell Ther. 2024; 46 Suppl 6:S144-S149.
PMID: 39095318
PMC: 11726068.
DOI: 10.1016/j.htct.2024.02.029.
Molecular and Clinical Insights in the Increasing Detection of in Adult Acute Myeloid Leukemia Patients.
DE Pinho Pessoa F, Dias Nogueira B, Machado C, Barreto I, DA Costa Machado A, Gadelha R
In Vivo. 2024; 38(4):2016-2023.
PMID: 38936913
PMC: 11215616.
DOI: 10.21873/invivo.13659.
A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor.
Zhao W, Mo M, Yu J, Cheng S, Long G, Luo Z
Med Oncol. 2024; 41(5):113.
PMID: 38602586
DOI: 10.1007/s12032-024-02324-6.
Exploring novel protein biomarkers for early-stage diagnosis and prognosis of T-acute lymphoblastic leukemia (T-ALL).
Singh V, Singh R, Kushwaha R
Hematol Transfus Cell Ther. 2024; 46 Suppl 6:S93-S111.
PMID: 38584071
PMC: 11726097.
DOI: 10.1016/j.htct.2024.02.016.
fusion genes in acute leukemias: genetic characterization of rare cases.
Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes L, Valerhaugen H
Front Oncol. 2024; 14:1371980.
PMID: 38571499
PMC: 10987735.
DOI: 10.3389/fonc.2024.1371980.
Factors influencing family resilience in adult patients with acute leukemia undergoing chemotherapy: A qualitative study.
Sun X, Wang Y, Lu X, Zhang S, Zhang Y
Asia Pac J Oncol Nurs. 2024; 11(4):100389.
PMID: 38495641
PMC: 10944098.
DOI: 10.1016/j.apjon.2024.100389.
Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.
DA Costa Machado A, Machado C, DE Pinho Pessoa F, Barreto I, Gadelha R, DE Sousa Oliveira D
Cancer Diagn Progn. 2024; 4(1):9-24.
PMID: 38173664
PMC: 10758851.
DOI: 10.21873/cdp.10279.
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.
Fu J, Imani S, Wu M, Wu R
Cancers (Basel). 2023; 15(19).
PMID: 37835417
PMC: 10571940.
DOI: 10.3390/cancers15194723.
Survival and predictors of mortality among acute leukemia patients on follow-up in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A 5-year retrospective cohort study.
Balta B, Gebreyohannis T, Tachbele E
Cancer Rep (Hoboken). 2023; 6(10):e1890.
PMID: 37783566
PMC: 10598244.
DOI: 10.1002/cnr2.1890.
MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells.
Dong M, Zhang G, Meng J, Liu B, Jiang D, Liu F
Stem Cells Int. 2023; 2023:2490943.
PMID: 37200633
PMC: 10188259.
DOI: 10.1155/2023/2490943.
Immunophenotypic characterization of acute leukemias in Bahia, Brazil.
Santos M, Santos A, Santos H, Santos L, Nascimento R, Torres A
Einstein (Sao Paulo). 2023; 21:eAO0117.
PMID: 36629681
PMC: 9785573.
DOI: 10.31744/einstein_journal/2023AO0117.
Bacillamide F, Extracted from Marine C89, Preliminary Effects on Leukemia Cell Lines.
Zhang S, Croppi G, Hu H, Li Y, Zhu C, Wu F
Biology (Basel). 2022; 11(12).
PMID: 36552221
PMC: 9774924.
DOI: 10.3390/biology11121712.
Leukemia can be Effectively Early Predicted in Routine Physical Examination with the Assistance of Machine Learning Models.
Yu C, Peng Y, Liu L, Wang X, Xiao Q
J Healthc Eng. 2022; 2022:8641194.
PMID: 36465253
PMC: 9715329.
DOI: 10.1155/2022/8641194.
An Integrated Study on the Differential Expression of the Gene Family in Cancer and Their Response to Chemotherapy Drugs.
Yin H, Fan X, Zhang Y, Zhao N, Zhao X, Yin K
Genes (Basel). 2022; 13(10).
PMID: 36292640
PMC: 9602029.
DOI: 10.3390/genes13101754.
Chemotherapy induces plasmatic antioxidant changes in pediatric patients with acute lymphoid leukemia B that correlate to disease prognosis.
Garbim M, Ellen Broto G, Trigo F, Victorino V, Tagliari de Oliveira S, Barbosa Sabatini D
Curr Res Immunol. 2022; 3:228-233.
PMID: 36189176
PMC: 9523196.
DOI: 10.1016/j.crimmu.2022.09.001.
Fabrication of Au/FeO/RGO based aptasensor for measurement of miRNA-128, a biomarker for acute lymphoblastic leukemia (ALL).
Soleimani Dinani H, Pourmadadi M, Yazdian F, Rashedi H, Ebrahimi S, Shayeh J
Eng Life Sci. 2022; 22(8):519-534.
PMID: 35936072
PMC: 9349134.
DOI: 10.1002/elsc.202100170.